Actively Recruiting

Age: 18Years - 75Years
All Genders
NCT02973412

Chronotype of Patients With Diabetes and Effect on Glycaemic Control

Led by University of Leicester · Updated on 2024-02-15

3447

Participants Needed

1

Research Sites

577 weeks

Total Duration

On this page

Sponsors

U

University of Leicester

Lead Sponsor

U

University Hospitals, Leicester

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of this study is to explore the associations between chronotype and glycaemic control, cardiometabolic health and other lifestyle factors.

CONDITIONS

Official Title

Chronotype of Patients With Diabetes and Effect on Glycaemic Control

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant is willing and able to give informed consent for participation in the study
  • Diagnosed with Type 1 diabetes or established Type 2 diabetes for more than 6 months
  • Male or female
  • Aged between 18 and 75 years inclusive
  • Body mass index (BMI) less than or equal to 45 kg/m�b2
  • No known sleep disorders except Obstructive Sleep Apnoea (OSA)
  • Currently on any glucose-lowering therapy (for Type 1 or Type 2 diabetes) or managing Type 2 diabetes through lifestyle changes
  • Has a good command of the English language
Not Eligible

You will not qualify if you...

  • Participant is unwilling or unable to give informed consent
  • Does not have a good command of the English language
  • Younger than 18 years or older than 75 years
  • Body mass index (BMI) greater than 45 kg/m�b2
  • Regular cannabis user (weekly use)
  • Has a terminal illness
  • Has a known sleep disorder other than Obstructive Sleep Apnoea (OSA)
  • Regular weekly use of certain medicines including wakefulness-promoting agents (Modafinil, Amphetamine derivatives, Methylphenidate), sedatives (benzodiazepines, Z-drugs like zopiclone, zolpidem, zaleplon), melatonin or melatonin analogues, Clonazepam, or drugs for nocturnal movement disorders

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Leicester Diabetes Centre, Leicester General Hospital

Leicester, United Kingdom, LE5 4PW

Actively Recruiting

Loading map...

Research Team

S

Sahar Khodabakhsh, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here